Prophylactic Hysterectomy During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for High Grade Tumors is Associated with Fewer Pelvic Recurrences

Ann Surg Oncol. 2023 Aug;30(8):4576-4578. doi: 10.1245/s10434-023-13608-y. Epub 2023 May 30.

Authors

Isabella S Florissi^#¹, Shannon N Radomski^#¹, Nolan M Winicki², Benjamin Shou¹, Fabian M Johnston, Jonathan B Greer³

Affiliations

¹ Division of Gastrointestinal Surgical Oncology, Peritoneal Surface Malignancy Program, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² School of Medicine, University of California Riverside, Riverside, CA, USA.
³ Division of Gastrointestinal Surgical Oncology, Peritoneal Surface Malignancy Program, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jgreer13@jhmi.edu.

^# Contributed equally.

No abstract available

Keywords: CRS/HIPEC; Organ preservation; Pelvic recurrence.

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Cytoreduction Surgical Procedures
Female
Humans
Hyperthermia, Induced*
Hyperthermic Intraperitoneal Chemotherapy
Neoplasms*
Recurrence
Retrospective Studies
Survival Rate

Grants and funding

T32 CA126607/CA/NCI NIH HHS/United States